Tech Company Financing Transactions
Monument Therapeutics Funding Round
Forster Foundation invested in a $1.3 million venture round for Monument Therapeutics. The funding round was announced on 10/15/2024.
Transaction Overview
Company Name
Announced On
10/15/2024
Transaction Type
Venture Equity
Amount
$1,300,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support the clinical development of MT1988, a novel treatment for the cognitive symptoms of schizophrenia.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Alderley Park, Congleton Road
Macclesfield, Cheshire, SK10 4TG
UK
Macclesfield, Cheshire, SK10 4TG
UK
Phone
Undisclosed
Website
Email Address
Overview
Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition. Our mission is to use precision medicine to develop effective treatment options for areas of high unmet need in psychiatry and neurology using our pioneering science and digital neuroscience expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Randeep Grewal
Chief Executive Officer
Jenny Barnett
Chief Financial Officer
Steve Plant
Chief Scientific Officer
Kiri Granger
VP - Bus. Development
Sheryl Caswell
Browse more venture capital transactions:
Prev: 10/14/2024: ApertureData venture capital transaction
Next: 10/15/2024: Beacon AI venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs